Search Results - "Yang, Junquan"
-
1
Mechanism of Iron Transport in the Triticum aestivum L.–Soil System: Perception from a Pot Experiment
Published in Applied sciences (01-07-2024)“…Iron is one of the necessary trace elements for plant growth and the human body. The ‘hidden hunger’ phenomenon in the human body caused by an imbalance of…”
Get full text
Journal Article -
2
Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer
Published in Oncotarget (08-09-2017)“…Novel tumor antigens and their related autoantibodies have tremendous potential for early diagnosis of non-small cell lung cancer (NSCLC). In this study, we…”
Get full text
Journal Article -
3
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
Published in Cancer communications (London, England) (01-09-2021)“…Background Previous studies have demonstrated the preclinical pharmacological and toxicological consistency, and clinical pharmacokinetic equivalence of…”
Get full text
Journal Article -
4
Wideband Harmonic Resonance Characteristics and Coordinated Damping Method for Distributed Generation Power Plants
Published in IEEE transactions on industrial electronics (1982) (01-10-2019)“…Impedance interactions generally exist within the networks of distributed generation power plants, which have the potential for wideband harmonic resonances…”
Get full text
Journal Article -
5
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (27-09-2022)“…IMPORTANCE: Programmed cell death ligand 1 inhibitors combined with chemotherapy has changed the approach to first-line treatment in patients with…”
Get full text
Journal Article -
6
Ginsenoside Rg1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages
Published in Acta biochimica et biophysica Sinica (01-02-2018)“…Abstract Ginsenoside Rg1 (Rg1) has been widely used in a broad range of cardiovascular and cerebral–vascular diseases because of its unique therapeutic…”
Get full text
Journal Article -
7
Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer
Published in Pathology, research and practice (01-08-2013)“…The aim of this study was to investigate the clinical significance of microRNA-181b (miR-181b) expression in non-small cell lung cancer (NSCLC). MiR-181b…”
Get full text
Journal Article -
8
Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial
Published in Lung cancer (Amsterdam, Netherlands) (01-09-2024)“…•Befotertinib demonstrated a robust efficacy with a long-term follow-up.•Patients with brain metastasis showed a clinical benefit from befotertinib.•The safety…”
Get full text
Journal Article -
9
Relationship Analysis on Leaf Nutrient of Blueberry Cultivars and Soil Nutrient in Guangdong Province
Published in Guangdong nong ye ke xue (01-03-2022)“…【Objective】Blueberry (Vaccinium spp.) is a plant species with no root hairs, resulting in weak uptake capacity of roots. Southern China is an emerging…”
Get full text
Journal Article -
10
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
Published in The lancet respiratory medicine (01-08-2024)“…Garsorasib (D-1553; InventisBio, Shangai, China), a potent KRASG12C inhibitor, has shown promising antitumour activity in patients with KRASG12C-mutated (ie,…”
Get full text
Journal Article -
11
Abstract CT170: D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156)
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase…”
Get full text
Journal Article -
12
Garsorasib in patients with KRAS G12C -mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
Published in The lancet respiratory medicine (10-06-2024)“…Garsorasib (D-1553; InventisBio, Shangai, China), a potent KRAS inhibitor, has shown promising antitumour activity in patients with KRAS -mutated (ie,…”
Get full text
Journal Article -
13
Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer
Published in Cancer research (Chicago, Ill.) (05-04-2024)“…Abstract Background: Garsorasib (D-1553), a potent KRAS G12C inhibitor, has previously demonstrated promising anti-tumor activity in KRAS G12C-mutated…”
Get full text
Journal Article -
14
广东主要蓝莓品种叶片营养与土壤养分关系分析
Published in 广东农业科学 (2022)“…S663.9; [目的]蓝莓(Vaccinium…”
Get full text
Journal Article